A detailed history of Geode Capital Management, LLC transactions in Kempharm, Inc stock. As of the latest transaction made, Geode Capital Management, LLC holds 914,264 shares of KMPH stock, worth $4.52 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
914,264
Previous 787,020 16.17%
Holding current value
$4.52 Million
Previous $3.89 Million 16.18%
% of portfolio
0.0%
Previous 0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 09, 2024

BUY
N/A
127,244 Added 16.17%
914,264 $4.52 Million
Q1 2024

May 13, 2024

BUY
N/A
57,841 Added 7.93%
787,020 $3.89 Million
Q4 2023

Feb 13, 2024

BUY
N/A
50,128 Added 7.38%
729,179 $3.6 Million
Q3 2023

Nov 13, 2023

BUY
N/A
7,475 Added 1.11%
679,051 $3.35 Million
Q2 2023

Aug 11, 2023

BUY
$4.94 - $6.29 $1.74 Million - $2.22 Million
352,558 Added 110.51%
671,576 $3.32 Million
Q1 2023

May 15, 2023

BUY
$4.13 - $6.27 $37,896 - $57,533
9,176 Added 2.96%
319,018 $1.75 Million
Q4 2022

Feb 13, 2023

BUY
$4.12 - $5.62 $21,382 - $29,167
5,190 Added 1.7%
309,842 $1.42 Million
Q3 2022

Nov 14, 2022

SELL
$4.5 - $6.85 $61,105 - $93,016
-13,579 Reduced 4.27%
304,652 $1.9 Million
Q2 2022

Aug 12, 2022

SELL
$4.02 - $5.21 $897,131 - $1.16 Million
-223,167 Reduced 41.22%
318,231 $1.42 Million
Q1 2022

May 13, 2022

BUY
$5.0 - $9.26 $179,355 - $332,165
35,871 Added 7.1%
541,398 $2.72 Million
Q4 2021

Feb 11, 2022

BUY
$7.6 - $10.26 $127,642 - $172,316
16,795 Added 3.44%
505,527 $4.4 Million
Q3 2021

Nov 12, 2021

BUY
$8.72 - $13.31 $138,456 - $211,336
15,878 Added 3.36%
488,732 $4.56 Million
Q2 2021

Aug 13, 2021

BUY
$8.52 - $15.47 $2.51 Million - $4.56 Million
294,874 Added 165.68%
472,854 $6.06 Million
Q1 2021

May 12, 2021

BUY
$5.6 - $13.47 $996,687 - $2.4 Million
177,980 New
177,980 $1.64 Million

Others Institutions Holding KMPH

About KEMPHARM, INC


  • Ticker KMPH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 34,493,600
  • Market Cap $170M
  • Description
  • KemPharm, Inc., a specialty pharmaceutical company, discovers and develops various proprietary prodrugs to treat serious medical conditions in the United States. The company utilizes its Ligand Activated Therapy technology to generate improved prodrug versions of FDA-approved drugs, as well as to generate prodrug versions of existing compounds t...
More about KMPH
Track This Portfolio

Track Geode Capital Management, LLC Portfolio

Follow Geode Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.